17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2
Alissa Brandes(University of California, San Francisco), Sabrina M. Ronen(University of California, San Francisco)
Cited by 31
Related Papers
Non-invasive in vivo assessment of IDH1 mutational status in glioma
|Nature Communications|2013|142
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival
|Scientific Reports|2019|64